Share on twitter
Share on LinkedIn
Share on Facebook
Email to a friend
Print pageFSRH Clinical Guideline: Progestogen-only Injectable (December 2014, Amended April 2019)
01 April 2019
This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables (depot medroxyprogesterone acetate (DMPA), Depo-Provera) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.
This document is up-to-date